Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy

BACKGROUND: Our aim was to assess the heterogeneity of high-risk (HR) prostate cancer managed with high-dose external beam radiotherapy (EBRT) with androgen deprivation therapy (ADT). METHODS: We identified 547 patients who were treated with modern EBRT from 1997 to 2013, of whom 98% received ADT. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Cagney, Daniel N., Dunne, Mary, O’Shea, Carmel, Finn, Marie, Noone, Emma, Sheehan, Martina, McDonagh, Lesley, O’Sullivan, Lydia, Thirion, Pierre, Armstrong, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539631/
https://www.ncbi.nlm.nih.gov/pubmed/28764689
http://dx.doi.org/10.1186/s12894-017-0250-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539631/
https://www.ncbi.nlm.nih.gov/pubmed/28764689
http://dx.doi.org/10.1186/s12894-017-0250-2

Ejemplares similares